Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: Implication of oxidative stress-PARP pathway

Pharmacology Biochemistry and Behavior

Volumn 114-115, Issue , 2013, Pages 43-51

  Jangra, Ashok ^a   Datusalia, Ashok Kumar ^a   Khandwe, Shriya ^a   Sharma, Shyam Sunder ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Behavioral changes; Diabetes; Melatonin; Nicotinamide; Oxidative stress; PARP

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINESTERASE; GLUTAMIC ACID; MALONALDEHYDE; MELATONIN; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETOGENESIS; DRUG EFFECT; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; HIPPOCAMPUS; NEUROCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; ROTAROD TEST; STREPTOZOCIN DIABETES;

ANIMALIA; RATTUS;

ACETYLCHOLINESTERASE; ACHE; ACTIVATOR PROTEIN-1; AIF; APOPTOSIS INDUCING FACTOR; B AP-1; BEHAVIORAL CHANGES; DIABETES; FOB; FUNCTIONAL OBSERVATIONAL BATTERY; IGF; INSULIN GROWTH FACTOR; MALONDIALDEHYDE; MAPK; MDA; MELATONIN; MITOGEN-ACTIVATED PROTEIN KINASE; NF-ΚB; NICOTINAMIDE; NUCLEAR FACTOR-KAPPA; O-PHTHALALDEHYDE; OPA; OXIDATIVE STRESS; PARP; POLY (ADP-RIBOSE) POLYMERASE; STREPTOZOTOCIN; STZ;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; MALE; MELATONIN; NIACINAMIDE; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84887601168     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.10.021     Document Type: Article

References (76)

1. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat Rev Neurosci 5 2004 S18 S25
2. N. Ashok kumar, L. Pari, and K.M. Ramkumar N-benzoyl-D-phenylalanine attenuates brain acetylcholinesterase in neonatal streptozotocin-diabetic rats Basic Clin. Pharmacol. Toxicol. 99 2006 246 250 (Pubitemid 44289746)
3. J. Beauquis, P. Roig, F. Homo-Delarche, A. De Nicola, and F. Saravia Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment Eur J Neurosci 23 2006 1539 1546
4. J. Beauquis, F. Saravia, J. Coulaud, P. Roig, M. Dardenne, and F. Homo-Delarche Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse Exp Neurol 210 2008 359 367
5. C.M. Bernstein, M.S. Stockwell, M.P. Gallagher, S.L. Rosenthal, and K. Soren Mental health issues in adolescents and young adults with type 1 diabetes: prevalence and impact on glycemic control Clin Pediatr (Phila) 52 2013 10 15
6. G.J. Biessels, A.C. Kappelle, B. Bravenboer, D.W. Erkelens, and W.H. Gispen Cerebral function in diabetes mellitus Diabetologia 37 1994 643 650 (Pubitemid 24210219)
7. G.-J. Biessels, A. Kamal, I.J.A. Urban, B.M. Spruijt, D.W. Erkelens, and W.H. Gispen Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment Brain Res 800 1998 125 135 (Pubitemid 28361929)
8. A. Brands, R.P.C. Kessels, E.H.F. de Haan, L.J. Kappelle, and G.J. Biessels Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels Eur J Pharmacol 490 2004 159 168 (Pubitemid 38482169)
9. J.D. Brioni Role of GABA during the multiple consolidation of memory Drug Dev Res 28 2004 3 27
10. T. Brismar, L. Maurex, G. Cooray, L. Juntti-Berggren, P. LindstrÃom, and K. Ekberg Predictors of cognitive impairment in type 1 diabetes Psychoneuroendocrinology 32 2007 1041 1051 (Pubitemid 350086822)
11. G.V. Chaitanya, A.J. Steven, and P.P. Babu PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration Cell Commun Signal 8 2010 31 41
12. M.A. Cousin, D.G. Nicholls, and J.M. Pocock Modulation of ion gradients and glutamate release in cultured cerebellar granule cells by ouabain J Neurochem 64 1995 2097 2104
13. S.E. Cruz-Morales, G.L. Quirarte, M.A. Diaz del Guante, and R.A. Prado-Alcala Effects of GABA antagonists on inhibitory avoidance Life Sci 53 1993 1325 1330
14. A. Das, D. Rai, M. Dikshit, G. Palit, and C. Nath Nature of stress: differential effects on brain acetylcholinesterase activity and memory in rats Life Sci 77 2005 2299 2311 (Pubitemid 41169964)
15. J. Emerit, M. Edeas, and F. Bricaire Neurodegenerative diseases and oxidative stress Biomed Pharmacother 58 2004 39 46 (Pubitemid 38117047)
16. Y. Feng, I.A. Paul, and M.H. LeBlanc Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat Brain Res Bull 69 2006 117 122 (Pubitemid 43375865)
17. J.S. Flier, L.H. Underhill, D.A. Greene, S.A. Lattimer, and A.A.F. Sima Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications N Engl J Med 316 1987 599 606 (Pubitemid 17024483)
18. J.F. Flood, J.E. Morley, and E. Roberts Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it Proc Natl Acad Sci U S A 89 1992 1567 1571
19. A. Galano, D.X. Tan, and R.J. Reiter Melatonin as a natural ally against oxidative stress: a physicochemical examination J Pineal Res 51 2011 1 16
20. A. Galano, D.X. Tan, and R.J. Reiter On the free radical scavenging activities of melatonin's metabolites. AFMK and AMK J Pineal Res 54 2013 245 257
21. T. Genovese, E. Mazzon, C. MuiÃ, N.S.A. Patel, M.D. Threadgill, and P. Bramanti Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma J Pharmacol Exp Ther 312 2005 449 457 (Pubitemid 40189541)
22. D.A. Ghareeb, and H.M. Hussen Vanadium improves brain acetylcholinesterase activity on early stage alloxan-diabetic rats Neurosci Lett 436 2008 44 47
23. L. Guariguata By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012 Diabetes Res Clin Pract 98 2012 524 525
24. P.O. Hassa, and M.O. Hottiger The functional role of poly (ADP-ribose) polymerase 1 as novel coactivator of NF-κB in inflammatory disorders Cell Mol Life Sci 59 2002 1534 1553 (Pubitemid 35239308)
25. S. Irwin Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse Psychopharmacology (Berl) 13 1968 222 257
26. J.H. Jung, E.J. Sohn, E.A. Shin, D. Lee, B. Kim, and D.-B. Jung Melatonin suppresses the expression of 45S preribosomal RNA and upstream binding factor and enhances the antitumor activity of puromycin in MDA-MB-231 breast cancer cells Evid Based Complement Alternat Med 2013 2013 879746
27. S.S. Kamboj, K. Chopra, and R. Sandhir Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes Metab Brain Dis 23 2008 427 443
28. M. Kameoka, K. Ota, T. Tetsuka, Y. Tanaka, A. Itaya, and T. Okamoto Evidence for regulation of NF-κB by poly (ADP-ribose) polymerase Biochem J 346 2000 641 649 (Pubitemid 30171024)
29. R.K. Kaundal, K.K. Shah, and S.S. Sharma Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation Life Sci 79 2006 2293
30. M.A. Khandkar, E. Mukherjee, D.V. Parmar, and S.S. Katyare Alloxan-diabetes alters kinetic properties of the membrane-bound form, but not of the soluble form, of acetylcholinesterase in rat brain Biochem J 307 1995 647
31. G.M. Knudsen, J. Jakobsen, D.I. Barry, A.M. Compton, and R.D. Tomlinson Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes Neuroscience 29 1989 773 777
32. A. Kuhad, and K. Chopra Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences Eur J Pharmacol 576 2007 34 42 (Pubitemid 47588254)
33. A. Kuhad, and K. Chopra Neurobiology of diabetic encephalopathy Drugs Future 33 2008 763 775
34. P. Kumar, R.K. Kaundal, S. More, and S.S. Sharma Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease Behav Brain Res 197 2009 398 403
35. A. Kumar, G. Negi, and S.S. Sharma JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence Diabetes Obes Metab 13 2011 750 758
36. M.K. Lakshmana, S. Rao, N.K. Dhingra, R. Ravikumar, B.L. Meti, and T.R. Raju Chronic (-) deprenyl administration increases dendritic arborization in CA3 neurons of hippocampus and AChE activity in specific regions of the primate brain Brain Res 796 1998 38 44 (Pubitemid 28343231)
37. J. Levy, J.R. Gavin, and J.R. Sowers Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 96 1994 260 273 (Pubitemid 24099226)
38. Z.G. Li, W. Zhang, G. Grunberger, and A.A.F. Sima Hippocampal neuronal apoptosis in type 1 diabetes Brain Res 946 2002 221 231 (Pubitemid 34876334)
39. Z. Li, W. Zhang, and A.A.F. Sima The role of impaired insulin/IGF action in primary diabetic encephalopathy Brain Res 1037 2005 12 24 (Pubitemid 40362377)
40. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
41. J.L. Mattsson, P.J. Spencer, and R.R. Albee A performance standard for clinical and functional observational battery examinations of rats Int J Toxicol 15 1996 239 254 (Pubitemid 26177329)
42. G. Negi, A. Kumar, R.K. Kaundal, A. Gulati, and S.S. Sharma Functional and biochemical evidence indicating beneficial effect of melatonin and nicotinamide alone and in combination in experimental diabetic neuropathy Neuropharmacology 58 2010 585 592
43. G. Negi, A. Kumar, and S.S. Sharma Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy Biochem Biophys Res Commun 391 2010 102 106
44. G. Negi, A. Kumar, and S.S. Sharma Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NFκB and Nrf2 cascades J Pineal Res 50 2011 124 131
45. J.S. Nisselbaum, and S. Green A simple ultramicro method for determination of pyridine nucleotides in tissues Anal Biochem 27 1969 212 217
46. E.A. Northam, D. Rankins, and F.J. Cameron Therapy insight: the impact of type 1 diabetes on brain development and function Nat Clin Pract Neurol 2 2006 78 86 (Pubitemid 43210248)
47. H. Ohkawa Assay for lipid peroxide in animal tissue by thiobarbituric acid reaction Anal Biochem 95 1979 351 358 (Pubitemid 9194347)
48. A. Ott, R.P. Stolk, F. Van Harskamp, H.A.P. Pols, A. Hofman, and M.M.B. Breteler Diabetes mellitus and the risk of dementia: the Rotterdam Study Neurology 53 1999 1937
49. 2, a newer thyrotropin-releasing hormone analog Epilepsy Behav 14 2009 48 53
50. B.S.S. Rao, T.R. Raju, and B.L. Meti Self-stimulation of lateral hypothalamus and ventral tegmentum increases the levels of noradrenaline, dopamine, glutamate, and AChE activity, but not 5-hydroxytryptamine and GABA levels in hippocampus and motor cortex Neurochem Res 23 1998 1053 1059 (Pubitemid 28350829)
51. R.J. Reiter, D.-X. Tan, M.P. Terron, L.J. Flores, and Z. Czarnocki Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions Acta Biochim Pol 54 1 2007
52. A.-R. Ressmeyer, J.C. Mayo, V. Zelosko, R.M. Sáinz, D.-X. Tan, and B. Poeggeler Antioxidant properties of the melatonin metabolite N 1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction Redox Rep 8 2003 205 213 (Pubitemid 37236233)
53. Y. Revsin, F. Saravia, P. Roig, A. Lima, E.R. de Kloet, and F. Homo-Delarche Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes Brain Res 1038 2005 22 31 (Pubitemid 40340957)
54. J.T.E. Richardson Cognitive function in diabetes mellitus Neurosci Biobehav Rev 14 1991 385 388
55. G. Riedel, and K.G. Reymann Metabotropic glutamate receptors in hippocampal long term potentiation and learning and memory Acta Physiol Scand 157 2003 1 19
56. M. Ristow Neurodegenerative disorders associated with diabetes mellitus J Mol Med 82 2004 510 529 (Pubitemid 39149861)
57. S.A. Rosales-Corral, D. Acuna-Castroviejo, A. Coto-Montes, J.A. Boga, L.C. Manchester, and L. Fuentes-Broto Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin J Pineal Res 52 2012 167 202
58. C. Ryle, C.K. Leow, and M. Donaghy Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus Muscle Nerve 20 1998 577 584
59. I.M.S. Sales, R.L.M. Freitas, G.B. Saldanha, G.F. Souza, and R.M. Freitas Choline acetyltransferase and acetylcholinesterase activities are reduced in rat striatum and frontal cortex after pilocarpine-induced seizures Neurosci Lett 469 2010 81 83
60. M. SÃnchez-Hidalgo, M. Lee, C.A. de la Lastra, J.M. Guerrero, and G. Packham Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines J Pineal Res 53 2012 366 373
61. R. Sandhir, D. Julka, and K. Gill Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes Pharmacol Toxicol 74 2009 66 71
62. F. Saravia, Y. Revsin, V. Lux― Lantos, J. Beauquis, F. Homo-Delarche, and A.F. De Nicola Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of streptozotocin-diabetic mice J Neuroendocrinol 16 2004 704 710 (Pubitemid 39162727)
63. S.S. Sharma, S.K. Srinivasan, S. Krishnamoorthy, A.M. Kaushal, and A.K. Bansal Preclinical safety pharmacological studies on the amorphous formulation of celecoxib Arzneim Forsch 59 2011 254 262
64. H.M. Sickmann, H.S. Waagepetersen, A. Schousboe, A.J. Benie, and S.D. Bouman Brain glycogen and its role in supporting glutamate and GABA homeostasis in a type 2 diabetes rat model Neurochem Int 60 2011 267 275
65. A.A.F. Sima Diabetes underlies common neurological disorders Ann Neurol 56 2004 459 461 (Pubitemid 39319334)
66. A.A.F. Sima, and Z-g Li The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats Diabetes 54 2005 1497 1505 (Pubitemid 40586682)
67. R. Strosznajder, R. Gadamski, and M. Walski Inhibition of poly (ADP-ribose) polymerase activity protects hippocampal cells against morphological and ultrastructural alteration evoked by ischemia-reperfusion injury Folia Neuropathol 43 2005 156
68. M. Suhail, and S.I. Rizvi Erythrocyte membrane acetylcholinesterase in type 1 (insulin-dependent) diabetes mellitus Biochem J 259 1989 897
69. D.X. Tan, L.D. Chen, B. Poeggeler, L.C. Manchester, and R.J. Reiter Melatonin: a potent, endogenous hydroxyl radical scavenger Endocr J 1 1993 57 60
70. +-ATPase activities in adult and aged rat brain Mech Ageing Dev 122 2001 491 501 (Pubitemid 32276011)
71. M. Tuzcu, and G. Baydas Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats Eur J Pharmacol 537 2006 106 110
72. M. Udayabanu, D. Kumaran, R.U. Nair, P. Srinivas, N. Bhagat, and R. Aneja Nitric oxide associated with iNOS expression inhibits acetylcholinesterase activity and induces memory impairment during acute hypobaric hypoxia Brain Res 1230 2008 138 149
73. H. Vlassara, M. Brownlee, and A. Cerami Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats Diabetes 32 1983 670 674 (Pubitemid 13062852)
74. J. Wang, W. Guo, W. Chen, W. Yu, Y. Tian, and L. Fu Melatonin potentiates the antiproliferative and pro-apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways J Pineal Res 54 2012 406 416
75. J. Yang, L.K. Klaidman, M.L. Chang, S. Kem, T. Sugawara, and P. Chan Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model Pharmacol Biochem Behav 73 2002 901 910 (Pubitemid 35246240)
76. O. Yavuz, M. Cam, N. Bukan, A. Guven, and F. Silan Protective effect of melatonin on β-cell damage in streptozotocin-induced diabetes in rats Acta Histochem 105 2003 261 266 (Pubitemid 37046259)